// November 27, 2023
Q&A: Building a More Resilient Medicines Supply Chain
In this conversation, US Pharmacopeia (USP) Director of Regulatory and Public Policy Developm
In this conversation, US Pharmacopeia (USP) Director of Regulatory and Public Policy Developm
USP’s supplier qualification standard became official on Aug.
The development of generic versions of innovator medicines is a global public health need.
Substandard and falsified (SF) medical products remain one of the most significant public health